Tag: life sciences
-
Stem Cells Aid Motor Functions in Spinal Cord Patients
First results from a clinical trial show stem cell treatments help restore some arm and hand functioning in patients with complete cervical spinal cord injury.
-
Computational Drug Discovery Company Launches
A new enterprise, Relay Therapeutics, is being formed for computer-driven discovery of new drugs based on the movements and interactions of protein molecules.
-
Patent Issued for Online Hearing Aid Calibration
A technology for fitting and programming a hearing aid online received a U.S. patent earlier this month, awarded to iHear Medical Inc.
-
Synthetic Viruses in Gene Therapy Licensed for Production
Techniques from academic research for developing synthetic viruses to deliver gene therapies are being licensed for commercial production and distribution.
-
Sanofi, Alphabet Create Diabetes Venture
Drug maker Sanofi and Verily Life Sciences, a division of Alphabet — parent company of Google — are creating Onduo, a joint venture to develop health management solutions for people with diabetes.
-
Trial Testing Diabetes Drug as Parkinson’s Treatment
A clinical trial has started to test a current drug for type 2 diabetes as a treatment for Parkinson’s disease.
-
Nanoparticle Therapy Start-Up Gains $4M in Early Funds
A start-up enterprise developing treatments for autoimmune disorders using protein-laden nanoparticles is raising $4 million in its first venture funding round.
-
$1.2M Challenge Seeking More Accurate Mammograms
A new challenge is seeking better computer models that interpret mammograms with fewer erroneous results, resulting in fewer unneeded medical tests.
-
Small Business Grant Funds Flu Therapy R&D
A biotechnology company in South Dakota is developing an influenza therapy, with backing from a National Institutes of Health program supporting research by small enterprises.
-
Orphan Status Granted for Hemophilia Genome Editing
Treatments using genome-editing techniques for hemophilia B, a rare blood clotting disease, received orphan therapy status from the U.S. Food and Drug Administration.